Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N van Geel

Showing results (151-160 of 233) with videos related to

Pageof 24
Sort By:
Journal of the American College of Surgeons|May 11, 1999
Relation between limb toxicity and treatment outcomes after isolated limb perfusion for recurrent melanomaB C Vrouenraets, G A Hart, A M Eggermont, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 22, 2001
Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan aloneB C Vrouenraets, A M Eggermont, A A Hart, et al.
Journal of the American College of Surgeons|June 1, 1994
Limb recurrence-free interval and survival in patients with recurrent melanoma of the extremities treated with normothermic isolated perfusionJ M Klaase, B B Kroon, A N van Geel, et al.
Annals of Plastic Surgery|December 6, 2005
Pathological internal mammary lymph nodes in secondary and tertiary deep inferior epigastric perforator flap breast reconstructionsStefan O P Hofer, Hinne A Rakhorst, Marc A M Mureau, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|April 21, 2012
The tolerance of reirradiation and hyperthermia in breast cancer patients with reconstructionsMarianne Linthorst, Gerard C van Rhoon, Albert N van Geel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 4, 2013
Effect of a combined surgery, re-irradiation and hyperthermia therapy on local control rate in radio-induced angiosarcoma of the chest wallM Linthorst, A N van Geel, E A Baartman, et al.
Journal of the American College of Surgeons|June 1, 1996
Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbsW M Klop, B C Vrouenraets, B N van Geel, et al.
Annals of Surgical Oncology|September 1, 2011
20 years experience of TNF-based isolated limb perfusion for in-transit melanoma metastases: TNF dose mattersJan P Deroose, Alexander M M Eggermont, Albertus N van Geel, et al.
Annals of Surgical Oncology|June 24, 1999
Absence of severe systemic toxicity after leakage-controlled isolated limb perfusion with tumor necrosis factor-alpha and melphalanB C Vrouenraets, B B Kroon, A C Ogilvie, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1993
Regional isolated perfusion with melphalan for patients with subungual melanomaB C Vrouenraets, B B Kroon, J M Klaase, et al.
Pageof 24

Showing results (151-160 of 233) with videos related to

Sort By:
Pageof 24
Journal of the American College of Surgeons|May 11, 1999
Relation between limb toxicity and treatment outcomes after isolated limb perfusion for recurrent melanomaB C Vrouenraets, G A Hart, A M Eggermont, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 22, 2001
Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan aloneB C Vrouenraets, A M Eggermont, A A Hart, et al.
Journal of the American College of Surgeons|June 1, 1994
Limb recurrence-free interval and survival in patients with recurrent melanoma of the extremities treated with normothermic isolated perfusionJ M Klaase, B B Kroon, A N van Geel, et al.
Annals of Plastic Surgery|December 6, 2005
Pathological internal mammary lymph nodes in secondary and tertiary deep inferior epigastric perforator flap breast reconstructionsStefan O P Hofer, Hinne A Rakhorst, Marc A M Mureau, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|April 21, 2012
The tolerance of reirradiation and hyperthermia in breast cancer patients with reconstructionsMarianne Linthorst, Gerard C van Rhoon, Albert N van Geel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 4, 2013
Effect of a combined surgery, re-irradiation and hyperthermia therapy on local control rate in radio-induced angiosarcoma of the chest wallM Linthorst, A N van Geel, E A Baartman, et al.
Journal of the American College of Surgeons|June 1, 1996
Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbsW M Klop, B C Vrouenraets, B N van Geel, et al.
Annals of Surgical Oncology|September 1, 2011
20 years experience of TNF-based isolated limb perfusion for in-transit melanoma metastases: TNF dose mattersJan P Deroose, Alexander M M Eggermont, Albertus N van Geel, et al.
Annals of Surgical Oncology|June 24, 1999
Absence of severe systemic toxicity after leakage-controlled isolated limb perfusion with tumor necrosis factor-alpha and melphalanB C Vrouenraets, B B Kroon, A C Ogilvie, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1993
Regional isolated perfusion with melphalan for patients with subungual melanomaB C Vrouenraets, B B Kroon, J M Klaase, et al.
Pageof 24